InFLAMES Seminar: Schwenk

When

November 11, 2022    
9:00 am - 10:00 am

Where

#_LOCATIONLINK
#_LOCATIONFULLLINE
#_LOCATIONMAP{100%,0}

November 11th at 09:00
On-site event
Arje Scheinin auditorium, Dentalia

Prof. Jochen Schwenk, KTH Stockholm, Sweden
The dynamic architecture of the circulating proteome in health and disease
Host: Urpo Lamminmäki (urplammi@utu.fi)

Dr. Jochen Schweck is a professor of translational proteomics in the School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH, Stockholm.  He is the scientific director of the Affinity Proteomics unit at Science for Life Laboratory (SciLifeLab) and his research group is associated to the Human Protein Atlas project. He acts as a chairman of HUPO’s Human Plasma Proteome project. His research interests include e.g., affinity-based plasma proteomics, translational biomarker discovery, multiplex immunoassay development and biostatistics.

 

Selected recent publications

Wesolowska-Andersen et al., “Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals : An IMI DIRECT study,” CELL REPORTS MEDICINE, vol. 3, no. 1, 2022.

  1. Yang et al., “Genetic Landscape of the ACE2 Coronavirus Receptor,” Circulation, vol. 145, no. 18, s. 1398-1411, 2022

Wu et al., “Elevated circulating follistatin associates with an increased risk of type 2 diabetes,” Nature Communications, vol. 12, no. 1, 2021.

Roxhed et al., “Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2,” Nature Communications, vol. 12, no. 1, 2021.

Bar et al., “A reference map of potential determinants for the human serum metabolome,” Nature, vol. 588, no. 7836, s. 135-140, 2020.

Suhre, M. I. McCarthy och J. M. Schwenk, “Genetics meets proteomics : perspectives for large population-based studies,” Nature reviews genetics, 2020.